Summary:
Phase 2 randomized clinical trial to evaluate ENX-102 medication for people who suffer with worry, sleep disturbances, and functional impairment due to anxiety.
Thirteen visits 8 are remote and 5 are on site.
Criteria:- 18 to 65 years old
- experiencing genearlized anxiety symptoms
- BMI of less than 40
- Do not have Bipolar or significant mental illness
Qualified Participants May Receive:
Free medication
Free physical exam
Free lab tests
Reimburssed of total $889.00 for completed participation. Each completed visit will be paid individually